Nuala Whitehead
Queen Alexandra Hospital
4 Papers
208 Citations
Nuala Whitehead is an academic researcher from Queen Alexandra Hospital. The author has contributed to research in topics: Guideline & Medicine. The author has an hindex of 3, co-authored 4 publications.
Chat about Author
Papers
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
Charles S. Haworth,John Banks,Toby Capstick,Andrew J. Fisher,Thomas Gorsuch,Ian F. Laurenson,Andrew R. Leitch,Michael R. Loebinger,Heather Milburn,Mark Nightingale,Peter Ormerod,Delane Shingadia,David Smith,Nuala Whitehead,Robert Wilson,R. Andres Floto,R. Andres Floto +16 more
TL;DR: Recommendations and recommendations on what samples should be used to detect pulmonary non-tuberculous mycobacterial infection and how to define lung disease attributable to NTM infection are presented.
British Thoracic Society Guideline for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
Charles S. Haworth,John Banks,Toby Capstick,Andrew J. Fisher,Thomas Gorsuch,Ian F Laurenson,Andrew R. Leitch,Michael R. Loebinger,Heather Milburn,Mark Nightingale,Peter Ormerod,Delane Shingadia,David Smith,Nuala Whitehead,Robert Wilson,R. Andres Floto +15 more
TL;DR: The full guideline for the management of non-tuberculous mycobacterial pulmonary disease is published in Thorax and a summary of the recommendations and good practice points is provided.
233
A UK-based resource to support the monitoring and safe use of anti-TB drugs and second-line treatment of multidrug-resistant TB
TL;DR: This document provides guidance for adverse effect monitoring in multidrug-resistant TB (MDR-TB) and includes recommendations for baseline tests, routine drug and toxicity monitoring guides as well as individual drug monographs for all drugs currently available in the UK to treat TB.
12
P97 Multi-drug resistant tuberculosis: The first UK guideline for treatment monitoring
TL;DR: A guideline to aid ADR monitoring in MDR-TB treatment is introduced to improve morbidity and mortality and reduce treatment costs and in due course it is planned to audit its use and publish its experiences.
2